WMSA
GILD icon

Weiss Multi-Strategy Advisers’s Gilead Sciences GILD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,000
Closed -$1.67M – 647
2022
Q3 		$1.67M Buy
+27,000
New +$1.7M 0.04% 429

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GILD Position: Q2 2023 in Review

Weiss Multi-Strategy Advisers sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 29,304 shares — an estimated $2.43M sold.

Weiss Multi-Strategy Advisers first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $10.9M in Q4 2013. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 29,304 Gilead Sciences shares in Q2 2023, an estimated $2.43M.
  • Weiss Multi-Strategy Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Weiss Multi-Strategy Advisers's Gilead Sciences position peaked at $10.9M in Q4 2013.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.